Filing status
- Accounts due
- 31 March 2027
- Last accounts
- 30 June 2025
- Conf. stmt due
- 3 January 2027
- Last conf. stmt
- 20 December 2025
Vifor Fresenius Medical Care Renal Pharma UK Limited
- Incorporated
- 6 January 2015 (11 years)
- Industry
- Other business support service activities n.e.c. (82990)
- Directors
- Juan Antonio De Lassaletta FernandezMarcus Gerhard Kracht
- Owned by
- Accounts type
- Small
- Region
- Greater London
- Address
- 5 New Street SquareLondonEC4A 3TW
Officers 3 active
Officer details are public data from the Companies House register.
Didier, Virginie
Secretary · Appointed 24 April 2024
Fernandez, Juan Antonio De Lassaletta
Director · Appointed 10 July 2023
Spanish
Born August 1971 (55)
Kracht, Marcus Gerhard
Director · Appointed 6 January 2015
German,Swiss
Born June 1974 (52)
Officer history (14 former)
27 June 2025
Resigned Kudzma, Domas as Secretary
24 April 2024
Appointed Didier, Virginie as Secretary
24 April 2024
24 April 2024
Appointed Kudzma, Domas as Secretary
2 April 2024
10 July 2023
Appointed Fernandez, Juan Antonio De Lassaletta as Director
10 July 2023
31 March 2022
31 March 2022
9 December 2020
9 December 2020
1 March 2019
Resigned Broeckers, Kirsten as Secretary
30 June 2018
14 June 2018
Resigned Kroenberg, Oliver Philip as Director
14 June 2018
Appointed Broeckers, Kirsten as Secretary
14 June 2018
14 June 2018
14 June 2018
14 June 2018
Resigned Windisch, Marco Julius Walter as Director
14 June 2018
Resigned Schulze, Stefan as Director
26 June 2017
Appointed Windisch, Marco Julius Walter as Director
6 January 2015
6 January 2015
6 January 2015
6 January 2015
6 January 2015
Appointed Kroenberg, Oliver Philip as Director
6 January 2015
6 January 2015
Appointed Schulze, Stefan as Director
6 January 2015
6 January 2015
6 January 2015
Appointed Kracht, Marcus Gerhard as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 9 August 2022
Owns 50–75% of shares
Holds 50–75% of voting rights
Corporate
Reg. no. 03061160
Former controllers (1)
9 August 2022
Ceased Vifor Pharma AG — Owns 75–100% of shares
Group structure 4 companies
Ownership group derived from the Companies House PSC register
CSL Behring UK Limited Owns 75–100% of shares
Vifor Fresenius Medical Care Renal Pharma UK Limited This company Owns 50–75% of shares
Vifor Pharma UK Limited Owns 75–100% of shares
Financials
Figures from 2019 accounts. Newer accounts, made up to 30 June 2025, are filed but not read yet. See them on Companies House
- Cash
- £687,478
- down £254,454 (27%)
- Turnover
- £8,597,931
- down £807,944 (9%)
- Profit Before Tax
- (£215,618)
- down £989,189 (128%)
- Current Ratio
- 1.1x
- Profit Margin
- -3%
- Return on Equity
- -31%
Balance sheet detail
| 2019 | |
|---|---|
| Current Assets | £5,496,178 |
| Debtors | £3,962,151 |
| Cash | £687,478 |
| Creditors (< 1 year) | £4,935,617 |
| Net Current Assets | £560,561 |
| Shareholder Funds | £560,561 |
| Turnover | £8,597,931 |
| Cost of Sales | £745,989 |
| Gross Profit | £7,851,942 |
| Admin Expenses | £8,067,560 |
| Staff Costs | £0 |
| Operating Profit | (£215,618) |
| Profit Before Tax | (£215,618) |
| Tax | (£39,507) |
| Profit for Period | (£176,111) |
Filings 65
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 22 January 2026 | Confirmation statement with no updates | 20 December 2025 | ||
| 14 January 2026 | Director's details changed | |||
| 22 December 2025 | Accounts for a small company | 30 June 2025 | ||
| 27 June 2025 | Termination of appointment of a secretary | |||
| 20 December 2024 | Confirmation statement with no updates | 20 December 2024 |
Some other companies at this address
Other companies in this industry
Brighton
London
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →